Sign Up to like & get
recommendations!
1
Published in 2017 at "Digestive Diseases and Sciences"
DOI: 10.1007/s10620-017-4872-8
Abstract: Due to the ever-increasing use of proton pump inhibitors (PPI), the therapeutic front line in gastroesophageal reflux disease (GERD) has changed. The successful healing of esophagitis, an elusive therapeutic target a mere 25 years ago,…
read more here.
Keywords:
heartburn;
reflux;
reflux disease;
non erosive ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "British Medical Journal"
DOI: 10.1136/bmj.j1936
Abstract: A 68-year-old woman presented to the hospital with intermittent retrosternal heartburn that had been ongoing for several years. Physical examination and electrocardiogram revealed no abnormalities. A plain chest radiograph was obtained (fig 1⇓). What does…
read more here.
Keywords:
heartburn;
intermittent heartburn;
woman intermittent;
woman ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "BMJ Open Gastroenterology"
DOI: 10.1136/bmjgast-2019-000278
Abstract: Background Drug exposure and corresponding antisecretory effects increase over the first 4–5 days of esomeprazole treatment. To date, this effect has not been correlated with symptomatic improvement. Therefore, the efficacy of esomeprazole was evaluated on…
read more here.
Keywords:
heartburn;
treatment;
free days;
heartburn free ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Digestive Diseases"
DOI: 10.1159/000496091
Abstract: Background and Aims: Proton pump inhibitors are effective at reducing heartburn. No studies have evaluated their efficacy in Ramadan. Dexlansoprazole has a unique active formulation independent of time-of-day dosing or food. The aim is to…
read more here.
Keywords:
heartburn;
week;
ramadan dexlansoprazole;
effective relieving ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Journal of Neurogastroenterology and Motility"
DOI: 10.5056/jnm22104
Abstract: Background/Aims Patients with gastroesophageal reflux disease (GERD) frequently experience nighttime heartburn and sleep disturbance. Tegoprazan is a new potassium-competitive acid blocker that can rapidly block acid secretion. This study aims to evaluate the efficacy of…
read more here.
Keywords:
heartburn sleep;
nighttime heartburn;
reflux disease;
heartburn free ... See more keywords